| 15-a-OH | 15-a-hydroxylase |
| 17,20-b-P | 17,20-b-dihydroxy-4-pregnen-3-one
|
| 17-BHD | 17-b-hydroxydehydrogenase
|
| 20-b-S | 17,20b,21-Trihydroxy-4-pregen-3-one
|
| 3-BHD | 3-b-hydroxydehydrogenase
|
| 5-HT | Serotonin
|
| 6-a-OH | 6-a-hydroxylase
|
| a.i. | Active ingredient
|
| ABG | Androgen binding globulin
|
| ABP | Androgen binding protein
|
| ACTH | Adrenocorticotrophic hormone
|
| AGD | Anogenital distance
|
| AhR | Arylhydrocarbon receptor
|
| ALH | Amplitude of lateral head displacement (of sperm)
|
| AR | Androgen receptor
|
| BrdU | 5-Bromodeoxyuridine
|
| CAF | Chorioallantoic fluid
|
| cAMP | Cyclic adenosine 3'5'-monophosphate
|
| CF | Condition factor
|
| ChE | Choline esterase
|
| CMP | Cypris major protein
|
| CoMFA | Comparative molecular field analysis
|
| CR | Cortisol receptor
|
| CYP450 | Cytochrome P450
|
| DbH | Dopamine b-hydroxylase
|
| DES | Diethylstilbestrol
|
| DHT | Dihydrotestosteron |
| EC100 | Effect concentration for 100% of the organisms exposed
|
| EC50 | Effect concentration for 50% of the organisms exposed
|
| EEQ | 17b-estradiol equivalent concentration
|
| ER | Estrogen receptor
|
| EROD | Ethoxyresorufin o-deethylase
|
| FOM | Final oocyte maturation
|
| FSH | Follicle stimulating hormone
|
| G6PD | Glucose-6-phosphate dehydrogenase
|
| GAM | Gonadal-adrenal mesonephros
|
| GnRH | Gonadotropin releasing hormone
|
| GR | Glucocorticoid receptor
|
| GSI | Gonado somatic index (gonadal weight/total body weight)
|
| GTH | Gonadotropin
|
| GVBD | Germinal vesicle breakdown
|
| hAR | Human androgen receptor
|
| hCG | Human chorionic gonadotropin
|
| hER | Human estrogen receptor
|
| hPR | Human progesterone receptor
|
| HSI | Hepatosomatic index (weight liver/total body weight)
|
| IC | Inhibition concentration
|
| IC50 | Inhibition concentration for 50% of the organisms exposed
|
| Ki | Inhibition constant
|
| LA/BC | Levator ani/bulbocavernosus
|
| LF | Lactoferrin
|
| LH | Luteinizing hormone
|
| LOAEL | Lowest observed adverse effect level
|
| LOEC(max) | Lowest concentration which induces maximal effect
|
| LOEL | Lowest observed effect level
|
| MCF-7 | Estrogen-sensitive human breast cancer cells (E-Screen assay)
|
| ME | Malic enzyme
|
| Meq | Molar equivalents
|
| MFO | Mixed function oxygenase
|
| mGTH | Mytus gonadotropin
|
| mPXR | Mouse pregnane X receptor
|
| NAOEL | No adverse observed effect level
|
| NE | Norepinephrine
|
| NOEL | No observed effect level
|
| oLH-RH | Ovine luteinizing hormone releasing hormone
|
| PAH | Polycyclic aromatic hydrocarbon
|
| PBDE | Polybrominated diphenyl ehter
|
| PCB | Polychlorinated biphenyl
|
| pC50 | Negative log of the concentration required to displace 50% of bound ligand
|
| PEPCK | Phosphoenolpyruvate carboxykinase
|
| PGC | Primordial germ cell
|
| PKC | Protein kinase C
|
| PMS | Pregnant mare serum
|
| PMSG | Pregnant mare serum gonadotropin
|
| PPR | Ratio of the precloacal length to the posterior lobe of the plastron (sexually dimorphic characteristic)
|
| PR | Progesterone receptor
|
| PRL | Prolactin
|
| PROD | Pentoxyresorufin o-deethylase
|
| PXR | Pregnane X receptor
|
| QSAR | Quantitative structure-activity relationship
|
| RAR | Retinoic acid receptor
|
| RBA | Relative binding affinity
|
| RTA | Relative transactivation activity
|
| rhER | Recombinant human estrogen receptor
|
| RPE | Relative proliferative effect compared to 17b-estradiol
|
| rtER | Rainbow trout estrogen receptor
|
| SAT | Sex accessory tissue
|
| SDN-POA | Sexually dimorphic nucleus of the preoptic area
|
| SHBG | Sex hormone binding globulin
|
| T3 | 3,3',5-Triiodothyronine
|
| T4 | Thyroxine
|
| TBT | Tributyltin
|
| TCDD | 2,3,7,8-Tetrachlorodibenzo-p-dioxin
|
| TEQ | TCDD toxic equivalent
|
| TH | Tyrosine hydroxulase
|
| TP | Testosterone propionate
|
| TR | Thyroid receptor
|
| TSD | Temperature-dependent sex determinantion
|
| TSH | Thyroid stimulating hormone (Thyrotropin)
|
| Vt | Vitellin |
| VTG | Vitellogenin
|
